{
    "code": "56025692",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025692",
    "time": "2019-05-10 03:14:05",
    "許可證字號": "衛部醫器輸字第025692號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/12\/06",
    "發證日期": "102\/12\/06",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602569206",
    "中文品名": "富士芮比歐腫瘤標誌品管液",
    "英文品名": "Fujirebio Tumor Marker Control",
    "效能": "本產品是一種定量測定的品管血清，用於監測實驗室中對以下分析物檢測程序的精密度：AFP、CA15-3、CA19-9、CA125、CEA、Ferritin、 HE4、PSA及游離PSA。",
    "醫器規格": "108-20\r\n以下空白",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1660品管材料(分析與非分析)",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M420097000  FUJIREBIO DIAGNOSTICS AB",
        "製造廠廠址": "ELOF LINDALVS GATA 13 SE-414 58 GOTEBORG SWEDEN",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560256920001-103-01-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025692&Seq=001&Type=9"
        },
        {
            "title": "560256920002-103-01-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025692&Seq=001&Type=8"
        }
    ]
}